CompaniesHelicon Therapeutics

Helicon Therapeutics

defunct
About

Defunct Company

Areas of Focus

Categories

MergedBankrupt, Merged, Sold, Renamed or Otherwise Defunct
Clinical Trials (3)
View all

Total Trials

3

As Lead Sponsor

3

As Collaborator

0

Total Enrollment

243

By Phase

PHASE2: 2PHASE1: 1

By Status

COMPLETED: 2ACTIVE_NOT_RECRUITING: 1

Recent Trials

NCT05972954Lead Sponsor
OMT-28 in Patients With Primary Mitochondrial Disease (PMD) (PMD-OPTION)
PHASE2Active, not recruiting
32 participants
Started: May 22, 2023 · Completed: Jun 30, 2025
NCT03906799Lead Sponsor
Study on OMT-28 in Maintenance of Sinus Rhythm in Patients With Persistent Atrial Fibrillation (AF)
PHASE2Completed
136 participants
Started: Mar 19, 2019 · Completed: Mar 20, 2020
NCT03078738Lead Sponsor
Safety and Pharmacokinetic Study of OMT-28 in Healthy Subjects
PHASE1Completed
75 participants
Started: Feb 8, 2017 · Completed: Mar 12, 2018
Funding History (1)
D
Jun 26, 2009
Filing
Related Companies
Dart Neuroscience----------------------------------------if You Believe Any Of This Information Is Incorrect
merged